Distillate Capital Partners LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.97 Billion distributed in 64 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Johnson & Johnson with a value of $116M, Amgen Inc with a value of $77.6M, Unitedhealth Group Inc with a value of $70.3M, Cigna Corp with a value of $69.3M, and Elevance Health, Inc. with a value of $63M.

Examining the 13F form we can see an increase of $121M in the current position value, from $1.85B to 1.97B.

Below you can find more details about Distillate Capital Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.97 Billion
Healthcare: $602 Million
Technology: $445 Million
Industrials: $350 Million
Consumer Cyclical: $270 Million
Energy: $109 Million
Financial Services: $87.9 Million
Communication Services: $78.3 Million
Consumer Defensive: $29.7 Million
Other: $1.27 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 64
  • Current Value $1.97 Billion
  • Prior Value $1.85 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 10 stocks
  • Additional Purchases 43 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Distillate Capital Partners LLC Portfolio

Follow Distillate Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Distillate Capital Partners LLC with notifications on news.